Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.

BMC infectious diseases - 2 Jan 2024

Mirzaei Hossein, Eybpoosh Sana, Mehrabi Fatemeh, Shojaei Mohammad Reza, Mirzazadeh Ali, Khezri Mehrdad, Nasiri Naser, Sharifi Hamid

Abstract excerpt

BACKGROUND: There is no systematic review on the prevalence of HIV drug resistance (HIVDR) in Iran. We aimed to estimate the prevalence of HIVDR among people living with HIV (PLHIV) in Iran. We assessed HIVDR prevalence in antiretroviral therapy (ART) naïve PLHIV (i.e., those without a history of ART) and PLHIV receiving ART. METHOD: We systematically searched Scopus, PubMed, Web of Science, Embase, Iranian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mutation

Share to Prevalence

Share to Reverse Transcriptase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 38166733
DOI: 10.1186/s12879-023-08916-3
PMCID: PMC10763184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.PMID 38166733Read ↗

Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.Semantic proximity Read ↗

Characterization of Pretreatment Drug Resistance among people living with HIV from 2018 to 2022 in Guangzhou, ChinaSemantic proximity Read ↗

Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China.Semantic proximity Read ↗

Pre-treatment and acquired HIV drug resistance in Hunan: a cross-sectional analysis of a growing challenge.Semantic proximity Read ↗

Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.Semantic proximity Read ↗

Brief communication: characteristics of primary drug resistance in newly diagnosed HIV-infected individuals in Ganzhou, China.Semantic proximity Read ↗

Transmitted HIV-1 Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey.Semantic proximity Read ↗

Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.Semantic proximity Read ↗

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018–2024Semantic proximity Read ↗

Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV/AIDS Individuals — China, 2015 and 2018Semantic proximity Read ↗

Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national study.Semantic proximity Read ↗

Transmitted Drug Resistance Among People Living With HIV-1 in Henan Province, China, 2025Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.